• SPX
  • $5,782.76
  • 1.23 %
  • $70.07
  • DJI
  • $42,221.88
  • 1.02 %
  • $427.28
  • N225
  • $38,662.17
  • 0.49 %
  • $187.49
  • FTSE
  • $8,172.39
  • -0.14 %
  • -$11.85
  • IXIC
  • $18,439.17
  • 1.43 %
  • $259.19
NewAmsterdam Pharma Company N.V. (NAMSW) Earning

NewAmsterdam Pharma Company N.V. (NAMSW) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$10.00

$0.1

(1%)

Day's range
$9.01
Day's range
$10.47

NewAmsterdam Pharma Company N.V. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/07/2024 Q2 2024 -$0.38 $2.13 M
05/08/2024 Q1 2024 -$0.98 $1.30 M
02/28/2024 Q4 2023 -$0.52 $1.59 M
09/29/2023 Q3 2023 -$0.56 $1.88 M
08/07/2023 Q2 2023 -$0.43 $1.57 M
08/07/2023 Q1 2023 -$0.47 $7.96 M
03/31/2023 Q4 2022 -$22.56 $1.29 M
11/28/2022 Q3 2022 -$23.19 $5.62 M
06/28/2022 Q2 2022 $0.75 $46.75 M
03/29/2022 Q1 2022 $0.75 $46.75 M
12/30/2021 Q4 2021 -$1.73 $0
09/29/2021 Q3 2021 -$0.82 $0
06/29/2021 Q2 2021 -$0.43 $0
03/30/2021 Q1 2021 -$0.43 $0
12/30/2020 Q4 2020 $0.00 $0
09/29/2020 Q3 2020 -$0.02 $0
06/29/2020 Q2 2020 -$0.02 $0
03/30/2020 Q1 2020 -$0.02 $0
 

NewAmsterdam Pharma Company N.V. Earnings: Frequently Asked Questions

  • How can I listen to NewAmsterdam Pharma Company N.V.'s earnings conference call?

    The conference call for NewAmsterdam Pharma Company N.V.'s latest earnings report can be listened to online.

  • How can I read NewAmsterdam Pharma Company N.V.'s conference call transcript?

    The conference call transcript for NewAmsterdam Pharma Company N.V.'s latest earnings report can be read online.

  • How much revenue does NewAmsterdam Pharma Company N.V. generate each year?

    NewAmsterdam Pharma Company N.V. (:NAMSW) has a recorded annual revenue of $12.76 M.

  • How much profit does NewAmsterdam Pharma Company N.V. generate each year?

    NewAmsterdam Pharma Company N.V. (:NAMSW) has a recorded net income of $12.76 M. NewAmsterdam Pharma Company N.V. has generated $-1.95 earnings per share over the last four quarters.

  • What is NewAmsterdam Pharma Company N.V.'s price-to-earnings ratio?

    NewAmsterdam Pharma Company N.V. (:NAMSW) has a price-to-earnings ratio of -22.95 and price/earnings-to-growth ratio is 0.65.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.